- 27 September
-
On September 26, 2024, TASS hosted an expert discussion in the format of a federal teleconference Moscow-St. Petersburg-Ekaterinburg-Novosibirsk-Vologda-Anapa, dedicated to discussing the role, reasons and mechanisms for stimulating In Ekaterinburg, Alexander Petrov, the Chairman of the Board of Directors of Medsintez Plant LLC, told the participants about Triazavirin, an innovative domestic antiviral drug, as a success case of private investment in science.
- 07 September
-
60 leading Russian reproductologists visited the pharmaceutical company Medsintez Plant in Novouralsk on September 4, 2024. This event was timed to coincide with the celebration of the 3rd anniversary of the opening of the production workshop for biotechnological substances for the reproductive health of women, as well as the Annual International Conference «Reproductive Technologies Today and Tomorrow» in Ekaterinburg. Leading experts and conference speakers visited the production of the first Russian follitropin alpha for the treatment of human infertility, Primapur®.
- 02 August
-
In 2024, the Medsintez Plant in collaboration with Tonghua Anrate Biopharmaceutical Co. launched the production of the substance and finished dosage forms of the world's first registered drug of recombinant human albumin. The drug was obtained using Pichia Pastoris cells by the recombinant DNA technology.
- 11 July
-
The Medsintez Plant has participated in an international business meeting with the delegation from the United Arab Emirates as part of the INNOPROM 2024 business program in Ekaterinburg. The meeting with representatives of the national Ministry of Industry, pharmaceutical and medical industries of the UAE was organized by the Ministry of Industry and Trade of the Russian Federation. The meeting was attended by the Deputy Minister of Industry and Advanced Technology of the UAE, representatives of Globalpharma, SayGen, Hayat Biotech, Abu Dhabi Medical Devices.
- Home
- Cluster members
- Institute of Chemical Engineering, Ural Federal University
Institute of Chemical Engineering, Ural Federal University
Institute of Chemical Engineering is one of leading institutes of the Ural Federal University, which does not stand still, constantly develops and keeps up to date.
Key competencies of the institute in the field of medicinal chemistry and pharmaceutical technologies are concentrated in departments, scientific laboratories, as well as in the Scientific, Educational and Innovation Center of Chemical and Pharmaceutical Technologies. A unique university in the Urals in terms of leading world-class scientific schools, technical equipment, laboratories, outstanding teachers and. scientists, educational programs. Pharmaceutical engineering is the hallmark of the Institute.
The Institute carries out active scientific and innovative work in the field of medical and pharmaceutical chemistry in cooperation with leading Russian and foreign centers. Graduates of the Institute work at chemical industry enterprises, enterprises manufacturing equipment for chemical industry, pharmaceuticals, in environmental protection institutions, in research and designing departments of biotechnological and microbiological enterprises, in production of medicinal substances, biopolymers using modern biotechnological methods, implementation of medical drug formulations and methods of quality control of raw materials, intermediate products and finished products, as well as in state regulatory organizations.
